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Introduction
Maintenance of phosphate homeostasis is of critical biological importance because high plasma phosphate concentrations (hyperphosphataemia) have been associated with soft tissue calcification and subsequent cardiovascular disease and death (Gutiérrez, 2013) . The use of plasma phosphate concentration as a marker for future outcomes in chronic kidney disease (CKD) patients has been proposed, with several studies showing that a reduction of plasma phosphate directly improves mortality rates in CKD animal models, as well as in patients (Finch et al. 2013; Russo et al. 2015) . The current treatments for hyperphosphataemia in CKD patients are oral dietary phosphate restriction and the use of intestinal phosphate binders; however, these options are less than ideal, because of poor patient compliance, the risk of malnutrition, gastrointestinal side-effects and the relatively poor efficacy of binders (Malberti, 2013; . This has led to the development of compounds that specifically inhibit the process of intestinal phosphate absorption, such as nicotinamide and phosphonoformic acid (PFA), which although effective in vitro, have varying effects on phosphate transport in in vivo models of CKD, as well as in CKD patients (Loghman-Adham & Motock, 1996; Brooks et al. 1997; Katai et al. 1999) . Recently, tenapanor, an inhibitor of the sodium-hydrogen exchanger NHE3, has been shown to act locally to reduce intestinal phosphate absorption. Uraemic five-sixth nephrectomized rats chronically treated with this drug have lower plasma phosphate concentrations, an improvement in the uraemic markers creatinine, blood urea nitrogen, fibroblast growth factor 23 (FGF-23) and albumin, and reduced ectopic vascular and soft tissue calcification (Labonté et al. 2015) . In addition, this compound has been shown to reduce plasma phosphate concentrations in humans, to have minimal systemic exposure and to be well tolerated, apart from a tendency to cause loose stool and diarrhoea (Johansson et al. 2016) . However, the exact mechanism(s) of action and overall clinical benefits are not known and are still under investigation.
While it is now widely accepted that the intestine is a suitable target for the control of hyperphosphataemia in CKD, our understanding of the cellular mechanisms responsible for dietary phosphate absorption is incomplete , and the role of the intestine in phosphate homeostasis is still debated. In 2007, Berndt and colleagues proposed a novel signalling mechanism, in which a duodenal phosphate load triggered acute phosphaturia in rats (Berndt et al. 2007a ). This reflex response was apparently independent of several key regulators of phosphate excretion, including elevated concentrations of plasma phosphate, parathyroid hormone (PTH), FGF-23 and secreted frizzled related protein-4, and renal innervation. Furthermore, infusion of duodenal mucosal homogenates also produced a phosphaturic response, suggesting the presence of a factor(s) within the intestinal mucosa that directly affects renal phosphate excretion. However, almost a decade later, no subsequent publication has confirmed or extended this finding, and so far, the proposed phosphaturic factor has not been identified. A confounding factor has been the concentration of phosphate used in the original study, which was in the supraphysiological molar range rather than the millimolar range and which might also have provided an additional osmotic stimulus (Berndt et al. 2007b) . Given that the physiological phosphate concentration within the small intestinal lumen is reported to be between 5 and 10 mM in the rat (Kirchner et al. 2008; Marks et al. 2015) , the aim of our study was to establish whether instilling a physiological phosphate load into the duodenum can trigger the signalling mechanism proposed by Berndt and colleagues (2007a) . In addition, in an effort to identify an intestinally derived and released phosphaturic factor, we used an ex vivo intestinal perfusion method to collect serosal fluid following luminal exposure to different phosphate loads. Studies were then performed in cultured opossum kidney (OK) cells as a bioassay to detect an acute effect on phosphate uptake when exposed to these collected serosal fluid samples.
Methods

Ethical approval
All procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act, 1986, Amendment Regulations 2012. The protocols were approved by the University College London (Royal Free Campus) Comparative Biology Unit Animal Welfare and Ethical Review Body (AWERB) committee.
Renal clearance of phosphate in anaesthetized rats
Experiments were performed on 41 male Sprague-Dawley rats purchased from Charles River (Margate, UK) aged 12-14 weeks (weighing 250-300 g). After a week of acclimation, 21 rats were fed ad libitum a standard commercial rat chow (Diet RM1, 0.52% phosphate; SDS Ltd, Witham, UK) and 20 rats were fed ad libitum a low-phosphate diet, containing 0.1% phosphate (SDS Ltd) for 7 days and allowed free access to water at all times.
Rats were then anaesthetized by I.P. injection with thiobutabarbital (Inactin, 120 mg kg −1 ; Sigma-Aldrich, Gillingham, UK), and monitoring of the pedal and corneal reflex was undertaken to ensure that deep anaesthesia was achieved before the femoral artery, jugular, bladder and trachea were cannulated. A cannula-sheathed 19 gauge needle was placed into the duodenum (2-3 cm from G. J. Lee and others the stomach pylorus) for instillation of phosphate or control solutions and secured with a ligature. Once surgery was completed, a 1 ml bolus of 0.05% fluorescein isothiocyanate (FITC)-inulin diluted in isotonic saline was given via the jugular cannula and the same concentration subsequently infused at a rate of 2.4 ml h −1 throughout the procedure to determine glomerular filtration rate (GFR). A 40 min period was allowed for surgical recovery and for FITC-inulin equilibration, after which rats underwent the following protocol. Four consecutive collections of urine were made, each of 15 min. A sample (500 μl) of arterial blood was collected via the femoral artery cannula at the start and end of each urine collection period for phosphate and FITC-inulin measurements. After the first control urine collection period, 1 ml of 10 mM or 1.3 M KH 2 PO 4 in buffer (mM: 16 Na-Hepes, 140 NaCl and 3.5 KCl, pH 5) or isosmolar control buffer without phosphate was administered into the duodenum, the needle removed, and the intestine tied off. Three subsequent collections following the duodenal bolus were made, after which the kidneys were removed and death was ensured by excising the heart. The cortex of both kidneys was dissected at 4°C and snap frozen for brush border membrane (BBM) vesicle preparation.
Brush border membrane vesicle preparation and Western blotting
Preparation of BBM vesicles and subsequent Western blotting has been described previously (Chichger et al. 2016) . Blotting was carried out using 40 μg of BBM protein heated at 90°C for 2 min. Rabbit polyclonal antibodies to the sodium-phosphate cotransporters NaPi-IIa and NaPi-IIc were generous gifts from Professor Jurg Biber, University of Zurich, Switzerland. Mouse monoclonal antibody for β-actin (Abcam, Cambridge, UK) was used as a loading control. Blots were visualized with enhanced chemiluminescence on a Fluor-S MultiImager system (BioRad, Hemel Hempstead, UK), and the abundance of each protein of interest was calculated relative to actin and expressed in arbitrary units.
Ex vivo intestinal perfusion for collection of serosal fluid
Experiments were performed on 30 male C57BL/6 mice (weighing ß25 g), bred at the Royal Free Campus Comparative Biology Unit. Mice were allowed ad libitum access to a standard rodent chow containing 0.52% phosphate (RM1 diet; SDS Ltd) and water until the day of experimentation. Mice were terminally anaesthetized with 50 mg kg −1 sodium pentobarbitone (Animalcare, York, UK) via an I.P. injection. Monitoring of the pedal and corneal reflexes was undertaken to ensure that deep anaesthesia was achieved before 10 cm segments of the proximal small intestine (from the ligament of Treitz) or the last 10 cm of distal small intestine was cannulated in vivo. Segments were perfused with Krebs buffer containing (mM): 4.6 KCl, 1 CaCl 2 .2H 2 O, 1.2 MgCl 2 .6H 2 O, 25 NaHCO 3, 118 NaCl, 1.2 KH 2 PO 4 and 10 glucose, oxygenated with 95% O 2 and 5% CO 2 to create a segmental flow at a rate of 1 ml min −1 . The intestine was subsequently removed and suspended in an organ chamber containing liquid paraffin at 37°C. Immediately after removal of the intestinal segment, mice were killed by cervical dislocation, and death was confirmed by cessation of the heart beat. The suspended intestinal segments were perfused for 30 min to allow them to equilibrate. Subsequently, serosal fluid was collected for 45 min, during which 1.2 mM phosphate was perfused through the segment. The solution was then either maintained with 1.2 mM phosphate or switched to one containing either 10 or 50 mM phosphate and serosal fluid collected after a further 45 min. In total, 10 mice were used for each of the different concentrations.
Phosphate uptake by OK cells
Opossum kidney cells, purchased from Public Health England Culture Collections (Porton Down, UK), were maintained in 80 cm 3 flasks (Nunc; Thermo Fisher Scientific, Loughborough, UK) at 37°C in air enriched with 5% CO 2 and cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Thermo Fisher Scientific, Loughborough, UK) supplemented with 10% fetal bovine serum and 100U penicillin and 0.1mg/ml streptomycin. The cells were subcultured every 7 days. For phosphate uptake experiments, 3 × 10 5 cells were seeded in six-well culture dishes (Nunc, Thermo Fisher Scientific) and maintained at 37°C with 5% CO 2 .
Phosphate uptake was measured 2 days after seeding into the six-well dishes. The growth medium was aspirated and the cells quickly rinsed twice with prewarmed (37°C) sodium-free uptake buffer of the following composition (mM): 137 ChCl, 5.4 KCl, 2.8 CaCl 2 , 1.2 MgSO 4 and 14 Hepes (−Na + ) (pH 7.4). The cells were then incubated for 30 min at 37°C with either 500 μl incubation buffer (containing 137 mM Na + for total transport or ChCl for Na + -independent transport) or 250 μl serosal fluid from the proximal or distal small intestine and 250 μl incubation buffer (±Na + ). For experiments using the sodium-dependent phosphate transporter inhibitor phosphoformic acid (PFA), a concentration of 1, 3, 7 or 10 mM PFA was included in the incubation buffer. After 30 min, the incubation buffer was aspirated and cells were washed three times with prewarmed sodium-free buffer (−Na + ). Phosphate transport was then initiated with the addition of 500 μl buffer containing 0.1 mM KH 2 PO 4 and 1 μCi ml −1 of 33 P ± Na + . After 5 min of incubation at 37°C, the buffer was aspirated and the cells were rinsed three times with ice-cold 154 mM ChCl. Cells were subsequently lysed with 0.1 M NaOH and 0.1% SDS. One hundred microlitres of cell lysate and 10 μl (at 1:100 dilution) of initial solution was used for scintillation counting with a Packard tri-carb 2900tr scintillation counter (Perkin Elmer, Beaconsfield, UK) The protein concentration was determined using the Bradford method (Bradford, 1976 3 mM phosphate into the duodenum induces phosphaturia in rats maintained on a normal-phosphate diet Urinary phosphate excretion (A), plasma phosphate concentration (B) and plasma PTH concentration (C) in rats fed a normal-phosphate diet and receiving a duodenal bolus of either 1.3 M phosphate or an isosmolar control buffer. Western blot analysis of NaPi-IIa (D) and NaPi-IIc (E) protein in brush border membrane vesicles prepared from kidneys obtained from the rats at the end of the procedure. Results are presented as means ± SD, n = 5-7. * P < 0.05, * * P < 0.01 compared with the control period before instillation of the phosphate bolus (A and B) using Student's paired t test or compared with the animals receiving the osmotically balanced control buffer (C) using Student's unpaired t test.
phosphate transport (uptake in the presence of sodium) or sodium-independent phosphate uptake (uptake in the absence of sodium).
Measurements of plasma PTH and phosphate
From the clearance studies, urinary and plasma phosphate were quantified using a QuantiChrom phosphate assay kit (Bioassay Sytems, San Francisco, CA, USA), and PTH in plasma samples taken at the end of the procedure was measured using an enzyme-linked immunoassay kit targeting rat bioactive PTH (Immutopics, San Clemente, CA, USA). All kits were used according to the manufacturer's instructions.
Statistical analysis
Data are presented as means ± SD, and statistical comparisons were performed using either Student's paired or unpaired t tests, with statistical significance taken as P < 0.05.
Results
A 1.3 M phosphate load in the duodenum induces phosphaturia in rats maintained on a normal diet
In keeping with Berndt et al. (2007a,b) , who also used 1.3 M phosphate, we showed that instillation of this dose into the duodenum induces phosphaturia. However, in contrast to their findings, this response occurred later, after 45 min, not at 20 min (Fig. 1A) , and was associated with a significant increase in plasma phosphate (Fig. 1B) and PTH concentration (Fig. 1C) . Interestingly, the phosphaturia was not associated with a change in protein levels of either NaPi-IIa or NaPi-IIc ( Fig. 1D and E, respectively). Representative Western blots for NaPi-IIa and NaPi-IIc can be found in Fig. 2 . In addition, the change in urinary phosphate excretion was independent of any change in GFR or mean arterial pressure (Table 1) .
A physiological phosphate load in the duodenum does not induce phosphaturia in rats maintained on a normal-phosphate diet
In contrast to the effect seen with 1.3 M phosphate, introduction of a more physiological phosphate load of 10 mM into the duodenum did not elicit an acute change in urinary phosphate excretion (Fig. 3A) . In addition, there was no change in plasma phosphate concentration (Fig. 3B ) or PTH concentration (Fig. 3C) , and NaPi-IIa and NaPi-IIc protein expression was unaffected ( Fig. 3D and E, respectively). Several reports have shown that rats chronically adapted to a low-phosphate diet and then acutely switched to a high-phosphate diet have significantly downregulated protein levels of renal NaPi-IIa, but not NaPi-IIc (Giral et al. 2009; Bourgeois et al. 2013) . In the present study, rats were chronically adapted to a low-phosphate diet for 7 days before the renal clearance experiments to establish whether this would exaggerate the renal response to a duodenal phosphate load. However, in contrast to animals on a normal-phosphate diet, instillation of 1.3 M phosphate did not induce phosphaturia in the low-phosphate-adapted animals ( Fig. 4A ) and had no effect on the protein levels of NaPi-IIa or NaPi-IIc ( Fig. 4D and E, respectively); but there was a significant increase in plasma phosphate concentration (Fig. 3B ) and in PTH concentration (Fig. 4C ). Animals given a physiological 10 mM intestinal phosphate challenge after being maintained on a low-phosphate diet showed Results are presented as means
no changes in phosphate excretion, plasma phosphate concentration or PTH concentration (Fig. 5) .
Serosal fluid collected from perfused mouse intestine does not alter phosphate uptake by OK cells
To investigate whether a factor is released from the intestinal mucosa that could affect renal phosphate reabsorption and thereby excretion, we perfused segments of mouse small intestine ex vivo with different phosphate concentrations and collected the serosal fluid. This approach has been used previously to establish the influence of glucose on secretion levels of the gut peptides gluco-insulintropic peptide (GIP), glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY; Mace et al. 2012) . The presence of a gut peptide in the collected serosal fluid capable of affecting phosphate transport in renal cells was investigated by exposing OK cells to the serosal fluid and performing 33 P uptake studies. Initially, cellular phosphate uptake by OK cells was validated using two methods. First, uptake was measured in sodium and sodium-free conditions to confirm the presence of sodium-dependent phosphate transport in this proximal tubule cell line, as described previously (Malmström & Murer, 1986; Thomas et al. 2016b) . Sodium-dependent transport accounted for 90.4% of total transport when 0.1 mM phosphate was included in the uptake buffer (Fig. 6A) . Second, PFA, a known blocker of sodium-dependent phosphate transport activity (Villa-Bellosta & Sorribas, 2009), was added to the incubation media. The PFA induced a dose-dependent inhibition of total phosphate uptake (Fig. 6A) , with significant inhibition achieved at 7 and 10 mM PFA. In contrast, incubation of OK cells with serosal fluid collected from proximal and distal segments of mouse small intestine perfused with 1.2, 10 and 50 mM phosphate had no effect on total (Fig. 6B ) or sodium-independent (Fig. 6C ) phosphate uptake by OK cells.
Discussion
Our knowledge of the processes regulating acute postprandial phosphate homeostasis is limited. In 2007, Berndt and colleagues proposed a mechanism by which the upper small intestine detects the presence of increased dietary phosphate and signals to the kidney to increase phosphate excretion rapidly to maintain phosphate balance (Berndt et al. 2007a ). This response was rapid and occurred within 20 min, and was independent of changes in PTH and FGF-23 (Berndt et al. 2007a) . However, whether a change in renal NaPi-IIa or NaPi-IIc protein abundance was responsible for the phosphaturia was not examined, although many studies have demonstrated that postprandial downregulation of NaPi-IIa in response to G. J. Lee and others ingestion of a high-phosphate diet occurs within 2-4 h (Levi et al. 1994; Capuano et al. 2005; Giral et al. 2009; Bourgeois et al. 2013) and that increased PTH, but not FGF-23, concentrations are responsible for the changes seen (Bourgeois et al. 2013) .
These differences raise the possibility that there may be two distinct mechanisms occurring in response to dietary phosphate; one that occurs rapidly and one more slowly. However, it is also important to note that the concentration of phosphate used by Berndt and colleagues was 1.3 M (Berndt et al. 2007b) and that this phosphate concentration is 1000-fold higher than the documented concentration found in rodent (5-10 mM; Kirchner et al. 2008; Marks et al. 2015) and human upper small intestinal contents (0.5 and 17.5 mM; Davis et al. 1983) . Although it might be argued that consumption of a meal or soft drink high in phosphate or phosphate preservatives could generate an intestinal phosphate concentration higher than the millimolar range reported above, it is worth noting that the highest value documented in humans (17.5 mM) was measured after consumption of a high-phosphate meal (Davis et al. 1983) . In the present study, we found, in keeping with the findings of Berndt and colleagues (Berndt et al. 2007b) , that urinary phosphate excretion increased in rats given a 1.3 M duodenal phosphate bolus. However, in our study this response was associated with a significant increase in plasma phosphate and PTH concentrations. Instillation of an osmotically balanced buffer had no effect on plasma phosphate or PTH concentrations or on urinary phosphate excretion, but it was noted, as expected with a hypertonic solution, that the intestinal contents were watery, with an increased presence of mucus, and that the segment became distended. In contrast to the effects seen with 1.3 M phosphate, duodenal instillation of the more physiological phosphate load of 10 mM did Figure 4 . Instillation of 1.3 M phosphate into the duodenum does not induce phosphaturia in rats maintained on a low-phosphate diet Urinary phosphate excretion (A), plasma phosphate concentration (B) and plasma PTH concentration (C) in rats fed a low-phosphate diet for 7 days before experimentation and receiving a duodenal bolus of either 1.3 M phosphate or an isosmolar control buffer. Western blot analysis of NaPi-IIa (D) and NaPi-IIc (E) protein in brush border membrane vesicles prepared from kidneys obtained from the rats at the end of the procedure. Results are presented as means ± SD, n = 5. * * P < 0.01 compared with control period before instillation of the phosphate bolus (B) using Student's paired t test. * * * P < 0.001 compared with the animals receiving the osmotically balanced control buffer (C) using Student's unpaired t test.
G. J. Lee and others
not affect any of the measurements made. Our findings show that although the kidney responds to changes in intestinal phosphate load, the response appears to occur only following exposure to very high levels of ingested phosphate. They also confirm previous rodent studies showing that ingestion of a diet high in phosphate (1.2%; Hernández et al. 1996; Giral et al. 2009; Bourgeois et al. 2013) or duodenal infusion of phosphate (Martin et al. 2005 ) induces a rapid increase in plasma phosphate concentration and subsequent release of PTH, and that this response, rather than release of a novel intestinal factor secreted independently of changes in plasma phosphate concentration, is likely to be responsible for the increase in renal phosphate excretion. In keeping with this suggestion is the finding that in humans, phosphaturia caused by an acute intestinal phosphate load is also associated with changes in plasma phosphate and PTH concentrations (Nishida et al. 2006; Bevilacqua et al. 2010; Scanni et al. 2014) . Interestingly, a recent study by (Thomas et al. 2016a) has shown that the phosphaturia caused (a.u.) ratio to actin (a.u.) Figure 5 . Instillation of 10 mM phosphate into the duodenum does not induce phosphaturia in rats maintained on a low-phosphate diet Urinary phosphate excretion (A), plasma phosphate concentration (B) and plasma PTH concentration (C) in rats fed a low-phosphate diet for 7 days before experimentation and receiving a duodenal bolus of either 10 mM phosphate or an isosmolar control buffer. Western blot analysis of NaPi-IIa (D) and NaPi-IIc (E) protein in brush border membrane vesicles prepared from kidneys obtained from the rats at the end of the procedure. Results are presented as means ± SD, n = 5.
by intravenous infusion of phosphate is associated with elevated plasma phosphate and PTH concentrations, but that while intragastric administration of the same phosphate load increases urinary phosphate excretion to the same extent as when given intravenously, it is related to elevated plasma PTH and not plasma phosphate concentrations, highlighting the key role for PTH in the phosphaturic response.
A number of studies have investigated the time course for changes in the abundance of the renal phosphate transporters in response to dietary phosphate ingestion. Switching from a chronic low-phosphate diet acutely to a high-phosphate diet induces downregulation in NaPi-IIa protein abundance after 2-4 h (Levi et al. 1994; Katai et al. 1997; Capuano et al. 2005; Segawa et al. 2005; Bourgeois et al. 2013) . In contrast, the time course for NaPi-IIc downregulation has been reported to be longer, ranging from 4-6 h (Segawa et al. 2005) to 48 h . Given that altered NaPi-IIa abundance in response to dietary phosphate is likely to be PTH mediated (Bourgeois et al. 2013) and that PTH can elicit NaPi-IIa internalization within 5 min (Bacic et al. 2006) , it can be assumed that reduced NaPi-IIa levels after an acute phosphate load occur within minutes, although this has not been definitely confirmed. Interestingly, our study demonstrates that even with significantly increased plasma phosphate and PTH concentration, we did not detect changes in either NaPi-IIa or NaPi-IIc protein abundance over the 45 min time course of the study. This is in keeping with the recent report that acute phosphaturia The ability of the phosphate uptake assay to detect sodium-dependent phosphate transport in OK cells was confirmed using sodium-free buffers and the phosphate transport inhibitor, phosphoformic acid (PFA; A). Total phosphate uptake (B) and sodium-independent phosphate uptake (C) were measured in OK cells exposed to serosal fluid collected from proximal and distal intestinal segments perfused with 1.2, 10 or 50 mM phosphate. Results are presented as means + SD, n = 4-5. * * P < 0.01, * * * P < 0.005 compared with uptake in the presence of sodium using Student's unpaired t test.
in response to intravenous phosphate infusion occurs without any detectable change in type II transporter activity or abundance (Thomas et al. 2016a ). Thus, the higher tubular load of phosphate, resulting from the elevated plasma phosphate concentration and maintained GFR, might explain the phosphaturia; alternatively, it has been proposed that changes in membrane lipid composition or sodium-hydrogen exchanger regulatory factor 1 (NHERF1) phosphorylation may be responsible (Thomas et al. 2016a) . Interestingly, rats maintained on a low-phosphate diet also had elevated plasma phosphate and PTH concentrations in response to a 1.3 M phosphate load, but this did not elicit a change in urinary phosphate excretion, at least over the time course studied. This finding could be a consequence of the well-documented increase in abundance of NaPi-IIa protein in response to a chronic low-phosphate diet and the potentially slower than expected adaptation of NaPi-IIa protein levels in these experimental conditions. The presence of the phosphaturic factor proposed by Berndt and colleagues (Berndt et al. 2007a ) was also investigated in vitro by performing phosphate uptake studies in OK cells (a widely used bioassay cell culture system to study renal proximal tubular phosphate transport) exposed to serosal fluid. These experiments also aimed to determine whether NaPi-IIb played a key role in intestinal phosphate sensing and subsequent release of the putative intestinal phosphatonin(s). For the collection of serosal fluid, we chose to use mouse intestinal segments, rather than rat, because the regional profile for NaPi-IIb in mice has been consistently reported, with NaPi-IIb protein almost exclusively located in the mouse ileum (Radanovic et al. 2005; Marks et al. 2006) , and transport studies using NaPi-IIb knockout mice have confirmed that phosphate absorption in this region is >90% NaPi-IIb mediated (Sabbagh et al. 2009 ). In contrast, in the rat phosphate absorption occurs maximally in the jejunum (Walling, 1977; Marks et al. 2006; Giral et al. 2009 ), but only ß30% of total transport in vivo can be resolved as sodium-dependent and, presumably, NaPi-IIb mediated . Therefore, by using defined segments of mouse intestine we believed we could make a clearer interpretation of the potential role of NaPi-IIb as a phosphate sensor. However, although we were able to demonstrate significant sodium-dependent and PFA-sensitive phosphate transport in these cells, no change in uptake was found after treatment with serosal fluid collected from either the proximal or distal mouse small intestine. This lack of response suggests that a modest and physiological intestinal phosphate load does not stimulate the secretion of a phosphaturic factor into serosal fluid.
In summary, our in vivo and in vitro data have been unable to demonstrate the presence of a gut-derived phosphaturic factor that mediates a rapid signalling mechanism between the small intestine and kidney that is independent of changes in plasma phosphate concentration and/or PTH concentration. Instead, our data are in keeping with the observation that a dietary phosphate load can cause postprandial hyperphosphataemia and stimulation of PTH release from parathyroid glands in order to maintain phosphate homeostasis (Hernández et al. 1996; Martin et al. 2005; Giral et al. 2009; Bourgeois et al. 2013 ). We also demonstrate that supraphysiological, but not physiological, intestinal phosphate loads elicit changes in plasma phosphate and PTH concentrations and that only when there is positive phosphate balance does this provoke a phosphaturic response. Further studies are needed to establish what intestinal phosphate loads correlate with the phosphate concentrations found in the human diet.
